Correction to: British Journal of Cancer (2012) 106, 1453–1459. doi:10.1038/bjc.2012.98
In revision of the above paper during the proofing and correction process, an earlier version of Figure 3 was resupplied for publication and, subsequently, published in error. The authors and publishers apologise for this mistake.
The correct Figure 3 and associated legend are shown below.
(A) High cytoplasmic SK1 expression in a low S1P4 expression background is associated with shorter disease-free survival compared with patients with low tumour S1P4 and SK1 expression. (B) High cytoplasmic SK1 expression in a low S1P4 expression background is associated with shorter disease-specific survival compared with patients with low tumour S1P4 and SK1 expression. (C) High SK1 or S1P4 expression is associated with shorter disease-specific survival compared with patients with low SK1 and S1P4 expression in their tumours.
Change history
24 January 2013
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
Additional information
The online version of the original article can be found at 10.1038/bjc.2012.98
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Ohotski, J., Long, J., Orange, C. et al. Erratum: Expression of sphingosine 1-phosphate receptor 4 and sphingosine kinase 1 is associated with outcome in oestrogen receptor negative breast cancer. Br J Cancer 107, 756 (2012). https://doi.org/10.1038/bjc.2012.352
Published:
Issue Date:
DOI: https://doi.org/10.1038/bjc.2012.352
